Vascular Prostheses Market

By Types;

Synthetic Prostheses, Biological Prostheses, and Biosynthetic Prostheses

By Application;

Artery and Vein

By End User;

Hospitals, Ambulatory Surgical Centres, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn776264232 Published Date: August, 2025

Vascular Prostheses Market Overview

Vascular Prostheses Market (USD Million)

Vascular Prostheses Market was valued at USD 6,872.46 million in the year 2024. The size of this market is expected to increase to USD 9,450.64 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.


Vascular Prostheses Market

*Market size in USD million

CAGR 4.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.7 %
Market Size (2024)USD 6,872.46 Million
Market Size (2031)USD 9,450.64 Million
Market ConcentrationHigh
Report Pages326
6,872.46
2024
9,450.64
2031

Major Players

  • Cardiva Medical Inc
  • CryoLife Inc
  • B. Braun Holding GmbH
  • LeMaitre Vaascular Inc
  • Sorin Group
  • Terumo Corporation
  • Getinge Group
  • Vygon SA

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Vascular Prostheses Market

Fragmented - Highly competitive market without dominant players


The Vascular Prostheses Market is gaining significant momentum as surgeons prioritize durable, efficient solutions for vessel repair in cardiovascular and peripheral procedures. Approximately 60% of bypass and aneurysm repair interventions now utilize advanced prosthetic grafts, reflecting a strong shift toward innovation in material science and biocompatibility. These trends are creating critical opportunities for manufacturers to develop high-performance grafts that support long-term patient outcomes and drive sustained market growth.

Collaborative Innovation Enhancing Product Development
The market is fueled by strong collaboration between medical device engineers, clinical researchers, and leading vascular surgery centers. Over 55% of product pipelines emerge from partnerships focused on rigorous clinical validation, long-term studies, and prototype refinement. Strategic merger activities are bolstering production scale, improving regulatory alignment, and enhancing distribution reach—supporting consistent growth and broader accessibility.

Strategic Deployment Supporting Market Adoption
Manufacturers are deploying effective strategies such as surgeon training programs, bundled procedure kits, and global tender partnerships to enhance familiarity and confidence. Consequently, approximately 70% of leading vascular surgery units now routinely stock branded prosthetic grafts. This targeted implementation is increasing clinician trust, driving institutional contracts, and powering market expansion across geographies.

Smart Grafts Driving Future Innovation
Looking ahead, the future outlook centers on innovation in smart vascular prostheses integrating biosensors, antimicrobial coatings, and drug-eluting capabilities. More than 75% of R&D efforts are focused on these next-gen solutions—which enable in vivo monitoring of graft integrity, localized drug delivery, and early detection of complications. These technological advancements are expected to catalyze sustained growth and long-term expansion in surgical vascular repair markets.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Types
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Vascular Prostheses Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging population demographics
        2. Rising prevalence of cardiovascular diseases
        3. Technological advancements
        4. Increasing surgical interventions
      2. Restraints
        1. High cost of prosthetic devices
        2. Regulatory challenges
        3. Risk of complications
        4. Limited skilled surgeons
      3. Opportunities
        1. Emerging markets expansion
        2. Innovations in biomaterials
        3. Minimally invasive techniques
        4. Collaborative research efforts
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Vascular Prostheses Market, By Types, 2021 - 2031 (USD Million)
      1. Synthetic Prostheses
      2. Biological Prostheses
      3. Biosynthetic Prostheses
    2. Vascular Prostheses Market, By Application, 2021 - 2031 (USD Million)
      1. Artery
      2. Vein
    3. Vascular Prostheses Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centres
      3. Others
    4. Vascular Prostheses Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Cardiva Medical Inc.
      2. CryoLife Inc.
      3. B. Braun Holding GmbH
      4. LeMaitre Vaascular Inc.
      5. Sorin Group
      6. Terumo Corporation
      7. Getinge Group
      8. Vygon SA
  7. Analyst Views
  8. Future Outlook of the Market